课题基金 / 基金详情

EXPRESSION AND REGULATION OF COLLAGEN SPECIFIC MOLECULAR CHAPERONE HSP47 IN PULMONARY EMPHYSEMA AND FIBROSIS

EXPRESSION AND REGULATION OF COLLAGEN SPECIFIC MOLECULAR CHAPERONE HSP47 IN PULMONARY EMPHYSEMA AND FIBROSIS
胶原蛋白特异性分子伴侣 HSP47 在肺气肿和纤维化中的表达和调节
批准号:
08670682
负责人:
ISHIHARA Yoko
金额:
$1.47万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1996
资助国家:
日本
项目状态:
已结题
起止时间:
1996 至 1997

项目摘要

项目成果

ISHIHARA Yoko的其他基金

相似基金

相关文献

中文摘要
翻译
本研究利用博莱霉素处理的小鼠、长期香烟烟雾暴露的小鼠和高表达肿瘤坏死因子-α的肺纤维化转基因小鼠,研究了胶原特异性分子伴侣HSP47在肺气肿和肺纤维化中的表达和调控。博莱霉素处理的小鼠肺组织羟脯氨酸含量从给药后4周开始增加,12周达到最大。与对照组相比,HSP47基因表达在治疗后4周和5周有一过性升高,但在12周时表达增加。而长期香烟烟雾暴露小鼠肺组织HSP47基因与对照组相比,差异无统计学意义(P>0.05)。转基因小鼠在5个月龄时出现HSP47基因抑制,1岁时与同龄非转基因小鼠相比也有这种趋势。肺功能、肺纤维化程度和肺组织羟脯氨酸含量在4~5个月龄时也达到最大值,此后一直维持到1岁以上。TG小鼠IV型胶原基因表达与HSP47基因表达平行,而不是I型和III型胶原基因表达。Tg组小鼠肺泡灌洗液中的总弹力略高于非Tg组,而MMP1基因在1~4个月龄时表达。上述结果提示,HSP47基因可能与不可逆性肺纤维化的进展有关,但不是纤维化的触发因素。然而,在实验模型中,我们不能明确HSP47基因与肺气肿的关系。HSP47基因调控可调节进行性肺纤维化中胶原的沉积。
英文摘要
This work was investigated the expression and regulation of collagen specific molecular chaperone HSP47 in pulmonary emphysema and fibrosis, using bleomycin-treated mice, long term cigarette smoke-exposed mice and TNF-alpha overexpression pulmonary-fibrosis transgenic (Tg) mice.Bleomycin-treated mice showed increase of lung hydroxyproline contents from week 4, and reached to a maximum at week 12 after administration. HSP47 gene expression was increased a transient at week 4 and 5 after treatment, but at week 12, compared with the control group. On the other hand, lung HSP47 gene did not show any marked changes during long term cigarette smoke-exposed mice (from day 4 to month 12) compared with the control group. Tg mice showed HSP47 gene suppression at 5 mo of age, this tendency was also observed at 1 year of age compared with same age of non-Tg mice. Pulmonary function pattern, the degree of fibrotic lesion in morphological findings, and lung hydroxyproline contents also reached to a maximum at 4-5 mo of age, and then this levels were maintained until over 1 year of age. Collagen typ IV gene expression in Tg mice paralleled HSP47 gene expression rather than collagen type (I) and (III). Total elastolytic activity in bronchoalveolar lavage showed a slight increase, whereas MMP-1 gene was expressed at from 1 to 4 mo of age in Tg mice compared with the non-Tg group. TGF-beta gene over expression was not observed during experimental period in the Tg mice.Above results suggest that HSP47 gene may be related to the progressive of non-reversible pulmonary fibrosis, but not as a trigger of fibrosis. However, we could not define the relationship between HSP47 gene and pulmonary emphysema in the experiment model. Collergen deposition could be regulated by control of HSP47 gene in the progressive pulmonary fibrosis.
期刊论文(32)
专著(0)
科研奖励(0)
会议论文
K.KOHRI: "The collagen-binding stress protein HSP47 gene is suppressed on lung fibrosis in tumor necrosis factor-α transgenic mice" Am J Respir Crit Care Med. 155. A569 (1997)
K.KOHRI:“胶原蛋白结合应激蛋白 HSP47 基因在肿瘤坏死因子-α 转基因小鼠的肺纤维化中受到抑制”Am J Respir Crit Care Med 155. A569 (1997)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Y.Ishihara,A.Nagai,J.Kagawa: "Expression of the collagen-binding stress protein HSP-47 gene in bleomycin treated mouse." FASEB. J10. A27 (1996)
Y.Ishihara、A.Nagai、J.Kakawa:“胶原蛋白结合应激蛋白 HSP-47 基因在博来霉素处理的小鼠中的表达。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Y.ISHIHARA: "Transforming growth factor-beta-independent fibrosing alveolitis in tumor necrosis factor-α transgenic mice" Am J Respir Crit Care Med. (in press). (1998)
Y.ISHIHARA:“肿瘤坏死因子-α 转基因小鼠中转化生长因子-β 依赖性纤维化肺泡炎”Am J Respir Crit Care Med(出版中)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
郡 和宏: "TNF-α過剰発現トランスジェニックマウスの肺線維化におけるコラーゲン特異的ストレスタンパクHSP47遺伝子発現の検討" 日胸疾会誌. 35. 249 (1997)
Kazuhiro Guni:“过度表达 TNF-α 的转基因小鼠肺纤维化中胶原特异性应激蛋白 HSP47 基因表达的检查”日本胸科学会杂志 35. 249 (1997)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
32
    Study of personal exposure and health effects of air pollutant transports in Northeast Asia
    • 批准号:
      23406001
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $12.48万
    • 财政年份:
      2011
    • 负责人:
      ISHIHARA Yoko
    • 依托单位:
    Study of nanomaterials on chronic health effect assessment according to endpoint of carcinogenesis and lung fibrosis
    • 批准号:
      22510035
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.83万
    • 财政年份:
      2010
    • 负责人:
      ISHIHARA Yoko
    • 依托单位:
    Investigation of quality and quantity of air pollution including a sandstorm and it's personal exposure in northern part of China
    • 批准号:
      20406001
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $10.98万
    • 财政年份:
      2008
    • 负责人:
      ISHIHARA Yoko
    • 依托单位:
    Health effect evaluation based on characteristics of nanoparticles
    • 批准号:
      19510036
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.91万
    • 财政年份:
      2007
    • 负责人:
      ISHIHARA Yoko
    • 依托单位:
    国内基金
    海外基金
    溶栓与神经保护双功效的 HSP47 抑制剂脂质体用于缺血性脑卒中治疗的研究
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      10.0万元
    • 批准年份:
      2024
    • 负责人:
      伍雯
    • 依托单位:
    HSP47抑制剂Col003抗血小板作用机制及其对大鼠脑缺血再灌注损伤影响的研究
    • 批准号:
      82160236
    • 项目类别:
      地区科学基金项目
    • 资助金额:
      34万元
    • 批准年份:
      2021
    • 负责人:
      刘竞丽
    • 依托单位:
    房颤患者心外膜脂肪组织通过旁分泌蛋白HSP47促进成纤维细胞胶原分泌的机制研究
    • 批准号:
      82100338
    • 项目类别:
      青年科学基金项目(C类)
    • 资助金额:
      30.0万元
    • 批准年份:
      2021
    • 负责人:
      王骋
    • 依托单位:
    HSP47通过诱导CCL2表达促进膀胱癌血管形成的机制研究
    • 批准号:
      82103431
    • 项目类别:
      青年科学基金项目(C类)
    • 资助金额:
      30.0万元
    • 批准年份:
      2021
    • 负责人:
      马文龙
    • 依托单位: